بدائل البحث:
improvement decrease » improvements increased (توسيع البحث), improvement success (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
improvement decrease » improvements increased (توسيع البحث), improvement success (توسيع البحث)
increase decrease » increased release (توسيع البحث), increased crash (توسيع البحث)
-
21
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
22
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
منشور في 2025"…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
-
23
-
24
-
25
-
26
Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
منشور في 2025الموضوعات: -
27
-
28
-
29
Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
منشور في 2025الموضوعات: -
30
Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).
منشور في 2025الموضوعات: -
31
Statistically significant linear increase in use of antidepressants during the observed time period.
منشور في 2025الموضوعات: -
32
BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma.
منشور في 2024الموضوعات: -
33
-
34
KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia.
منشور في 2025الموضوعات: -
35
-
36
-
37
-
38
-
39
-
40
qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs.
منشور في 2025الموضوعات: